Camtek Ltd. $CAMT Shares Sold by Truvestments Capital LLC

Key Points

• Truvestments Capital LLC has decreased its holdings in Camtek Ltd. by 44.9% in the first quarter, now owning 8,031 shares valued at approximately $471,000.
• Several institutional investors have increased their stakes in Camtek, with Clal Insurance raising its stake by 27.8% to 2,134,671 shares, worth $123.6 million.
• Research analysts have issued positive ratings and raised price targets for Camtek, with revisions including a price target increase to $105 from Jefferies Financial Group.

Truvestments Capital LLC decreased its position in Camtek Ltd. (NASDAQ:CAMT - Free Report) by 44.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,031 shares of the semiconductor company's stock after selling 6,534 shares during the period. Truvestments Capital LLC's holdings in Camtek were worth $471,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Clal Insurance Enterprises Holdings Ltd raised its stake in Camtek by 27.8% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,134,671 shares of the semiconductor company's stock worth $123,622,000 after acquiring an additional 464,671 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its stake in Camtek by 27.6% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,448,441 shares of the semiconductor company's stock worth $84,922,000 after acquiring an additional 312,988 shares during the last quarter. Vanguard Group Inc. raised its stake in Camtek by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 1,002,302 shares of the semiconductor company's stock worth $58,715,000 after acquiring an additional 18,316 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. raised its stake in Camtek by 1.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 980,074 shares of the semiconductor company's stock worth $57,462,000 after acquiring an additional 16,200 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in Camtek by 46.1% in the 4th quarter. The Manufacturers Life Insurance Company now owns 483,245 shares of the semiconductor company's stock worth $39,032,000 after acquiring an additional 152,529 shares during the last quarter. Hedge funds and other institutional investors own 41.93% of the company's stock.

Camtek Price Performance

Shares of NASDAQ:CAMT traded down $5.35 during trading on Tuesday, reaching $77.37. 184,467 shares of the company's stock traded hands, compared to its average volume of 457,056. Camtek Ltd. has a fifty-two week low of $47.41 and a fifty-two week high of $110.73. The company has a quick ratio of 4.38, a current ratio of 5.41 and a debt-to-equity ratio of 0.32. The firm has a market cap of $3.53 billion, a PE ratio of 28.34, a P/E/G ratio of 2.15 and a beta of 1.35. The company has a 50-day simple moving average of $88.22 and a 200-day simple moving average of $74.55.

Camtek (NASDAQ:CAMT - Get Free Report) last posted its earnings results on Tuesday, August 5th. The semiconductor company reported $0.79 EPS for the quarter, meeting analysts' consensus estimates of $0.79. Camtek had a return on equity of 23.95% and a net margin of 28.36%.The firm had revenue of $123.32 million for the quarter, compared to analysts' expectations of $121.57 million. During the same period last year, the firm earned $0.66 EPS. The company's quarterly revenue was up 20.2% on a year-over-year basis. Camtek has set its Q3 2025 guidance at EPS. As a group, analysts predict that Camtek Ltd. will post 2.93 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CAMT shares. Jefferies Financial Group set a $105.00 price objective on Camtek and gave the company a "buy" rating in a research note on Tuesday, August 5th. Cantor Fitzgerald set a $80.00 price objective on Camtek and gave the company a "neutral" rating in a research note on Tuesday, June 24th. Bank of America lowered Camtek from a "buy" rating to a "neutral" rating and set a $95.00 price objective for the company. in a research note on Wednesday, August 6th. Needham & Company LLC lifted their price objective on Camtek from $80.00 to $98.00 and gave the company a "buy" rating in a research note on Tuesday, August 5th. Finally, Northland Securities set a $105.00 price objective on Camtek in a research note on Wednesday, May 14th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Camtek presently has an average rating of "Moderate Buy" and an average target price of $96.10.

Camtek Company Profile

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.